Rituximab Therapy in Anti-Myelin Associated Glycoprotein Patients With Characteristics of Good Responders - Join Clinical Trial NCTNCT05136976
How to Join This Clinical Trial - NCTNCT05136976
Learn how to participate in this PHASE3 trial studying an investigational therapy for Anti-MAG Neuropathy. This study is currently enrolling participants.
Am I Eligible for This Clinical Trial?
This clinical research study is looking for participants with Anti-MAG Neuropathy. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.
- Condition Being Studied
- Anti-MAG Neuropathy
- Treatment Being Tested
- Investigational treatment
- Study Phase
- PHASE3 - Large-scale efficacy study
- Enrollment Status
- Currently enrolling participants
- Study Identifier
- NCTNCT05136976 - ClinicalTrials.gov Identifier
- Sponsored By
- Study sponsor
What to Expect as a Participant
Participating in this clinical trial involves:
- Initial screening to determine eligibility
- Regular study visits and health assessments
- Receiving the study treatment or placebo
- Medical monitoring and follow-up care
- Contributing to medical research that may help others
- Potential access to new treatments before they're widely available
Clinical Trial Benefits and Compensation
Participants in this clinical research study may receive:
- Close medical monitoring by healthcare professionals
- Access to potential new treatments
- Compensation for time and travel (varies by study)
- No-cost study-related medical care
- The opportunity to help advance medical knowledge
Where Is This Clinical Trial Located?
This study is enrolling participants at 15 locations. Find a study site near you:
Clinical Research Site
Brest, 29200 - France
Status: NOT_YET_RECRUITING
Clinical Research Site
Grenoble, 38700 - France
Status: NOT_YET_RECRUITING
Clinical Research Site
Lille, 59037 - France
Status: NOT_YET_RECRUITING
Clinical Research Site
Limoges, 87170 - France
Status: NOT_YET_RECRUITING
Clinical Research Site
Lyon, 69002 - France
Status: NOT_YET_RECRUITING
Clinical Research Site
Marseille, 13915 - France
Status: NOT_YET_RECRUITING
Clinical Research Site
Nancy, 54035 - France
Status: NOT_YET_RECRUITING
Clinical Research Site
Nantes, - France
Status: NOT_YET_RECRUITING
Clinical Research Site
Nice, 06031 - France
Status: NOT_YET_RECRUITING
Clinical Research Site
Paris, 75651 - France
Status: NOT_YET_RECRUITING
And 5 more locations available. Contact us to find the nearest participating site.
How to Enroll in This Study
To learn more about participating in this PHASE3 clinical trial for Anti-MAG Neuropathy:
- Review the eligibility criteria with your healthcare provider
- Contact the study team for a pre-screening interview
- Schedule an in-person screening visit if eligible
- Review and sign the informed consent form
- Begin participation in the clinical trial
Why Choose Quri.ai Study Finder
Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:
- Discover clinical trials before competitors
- Access exclusive contact information
- Track sponsor pipelines and opportunities
- Connect with decision makers directly
- Win more business partnerships